| Literature DB >> 32882768 |
Dae San Yoo1, Seung Ju Lee1, Song Ee Kim1, Soo Chan Kim2, Sang Eun Lee3.
Abstract
Entities:
Year: 2020 PMID: 32882768 PMCID: PMC7471079 DOI: 10.3349/ymj.2020.61.9.831
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Fig. 1Clinical features and genetic information of the patient. (A) Direct sequencing (Sanger method) of DNA identified compound heterozygous missense mutations in c.113G>T (p.C38F) in exon 3 and c1274A>C (p.Q425P) in exon 11 of ITGB4 in the patient's DNA. (B) Clinical features of the patient at age 22. (C) Representative immunofluorescence staining images of integrin β4, plectin, and integrin β6 in the skin of the patient and healthy individual (scale bars=50 µm).